Cao Y, Zhang X, Fearon I, Li J, Chen X, Xiong Y
Front Public Health. 2024; 12:1433678.
PMID: 39606086
PMC: 11600979.
DOI: 10.3389/fpubh.2024.1433678.
Fearon I, Cordery S, Fitzpatrick M, Weaver S, Stevenson M, Grandolfo E
Cureus. 2024; 16(7):e65773.
PMID: 39211653
PMC: 11361622.
DOI: 10.7759/cureus.65773.
Grandolfo E, Ogden H, Fearon I, Malt L, Stevenson M, Weaver S
Cureus. 2024; 16(2):e54228.
PMID: 38496069
PMC: 10944327.
DOI: 10.7759/cureus.54228.
Qureshi M, Mumtaz M
Prev Med Rep. 2024; 38:102619.
PMID: 38375170
PMC: 10874858.
DOI: 10.1016/j.pmedr.2024.102619.
Hendlin Y, Han E, Ling P
BMJ Glob Health. 2024; 9(2).
PMID: 38316465
PMC: 10859997.
DOI: 10.1136/bmjgh-2023-013866.
An assessment of nicotine pharmacokinetics and subjective effects of the pulze heated tobacco system compared with cigarettes.
McDermott S, Reichmann K, Mason E, Fearon I, OConnell G, Nahde T
Sci Rep. 2023; 13(1):9037.
PMID: 37270650
PMC: 10239516.
DOI: 10.1038/s41598-023-36259-1.
Advanced Materials Design for Adsorption of Toxic Substances in Cigarette Smoke.
Zeng T, Liu Y, Jiang Y, Zhang L, Zhang Y, Zhao L
Adv Sci (Weinh). 2023; 10(22):e2301834.
PMID: 37211707
PMC: 10401148.
DOI: 10.1002/advs.202301834.
What Can Current Biomarker Data Tell Us About the Risks of Lung Cancer Posed by Heated Tobacco Products?.
Braznell S, Campbell J, Gilmore A
Nicotine Tob Res. 2023; 26(3):270-280.
PMID: 37210693
PMC: 10882439.
DOI: 10.1093/ntr/ntad081.
Comparative study of the effects of cigarette smoke versus next-generation tobacco and nicotine product extracts on inflammatory biomarkers of human monocytes.
Giebe S, Brux M, Hofmann A, Lowe F, Breheny D, Morawietz H
Pflugers Arch. 2023; 475(7):823-833.
PMID: 37081240
PMC: 10264276.
DOI: 10.1007/s00424-023-02809-9.
Preliminary toxicological assessment of heated tobacco products: A review of the literature and proposed strategy.
Dempsey R, Rodrigo G, Vonmoos F, Gunduz I, Belushkin M, Esposito M
Toxicol Rep. 2023; 10():195-205.
PMID: 36748021
PMC: 9898577.
DOI: 10.1016/j.toxrep.2023.01.008.
Evaluation of behavioural, chemical, toxicological and clinical studies of a tobacco heated product glo™ and the potential for bridging from a foundational dataset to new product iterations.
Goodall S, Gale N, Thorne D, Hadley S, Prasad K, Gilmour I
Toxicol Rep. 2022; 9:1426-1442.
PMID: 36561950
PMC: 9764197.
DOI: 10.1016/j.toxrep.2022.06.014.
Does a human rights-based approach to harm reduction support commercialized harm reduction? Brief research.
Sircar N, Fleming M, Bialous S
Front Public Health. 2022; 10:1001036.
PMID: 36388311
PMC: 9645767.
DOI: 10.3389/fpubh.2022.1001036.
Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study.
Azzopardi D, Haswell L, Frosina J, McEwan M, Gale N, Thissen J
JMIR Res Protoc. 2022; 11(10):e39785.
PMID: 36201395
PMC: 9585440.
DOI: 10.2196/39785.
An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy.
Hardie G, Gale N, McEwan M, Oscar S, Ziviani L, Proctor C
Sci Rep. 2022; 12(1):14701.
PMID: 36038580
PMC: 9424205.
DOI: 10.1038/s41598-022-19167-8.
Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking.
Gale N, McEwan M, Hardie G, Proctor C, Murphy J
Intern Emerg Med. 2022; 17(7):2017-2030.
PMID: 36036342
PMC: 9522838.
DOI: 10.1007/s11739-022-03062-1.
A Randomized, Controlled Study to Assess Biomarkers of Exposure in Adult Smokers Switching to Oral Nicotine Products.
Edmiston J, Liu J, Wang J, Sarkar M
J Clin Pharmacol. 2022; 62(11):1445-1458.
PMID: 35730535
PMC: 9804531.
DOI: 10.1002/jcph.2098.
A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.
Fearon I, Gilligan K, Seltzer R, McKinney W
Harm Reduct J. 2022; 19(1):57.
PMID: 35655314
PMC: 9160848.
DOI: 10.1186/s12954-022-00638-0.
A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette.
McEwan M, Azzopardi D, Gale N, Camacho O, Hardie G, Fearon I
Eur J Drug Metab Pharmacokinet. 2021; 47(2):211-221.
PMID: 34923602
PMC: 8917032.
DOI: 10.1007/s13318-021-00742-9.
Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial.
Gale N, McEwan M, Camacho O, Hardie G, Proctor C, Murphy J
Intern Emerg Med. 2021; 16(8):2201-2212.
PMID: 34196886
PMC: 8563516.
DOI: 10.1007/s11739-021-02798-6.
A 6-month inhalation toxicology study in Apoe mice demonstrates substantially lower effects of e-vapor aerosol compared with cigarette smoke in the respiratory tract.
Wong E, Szostak J, Titz B, Lee T, Wong S, Lavrynenko O
Arch Toxicol. 2021; 95(5):1805-1829.
PMID: 33963423
PMC: 8113187.
DOI: 10.1007/s00204-021-03020-4.
